Loading lessons…
Peptide learning paths
Learn peptides step by step
Curated lessons across 8 learning paths — from first concepts to trial summaries and practical protocols. Pick your level, follow the curriculum, and build real understanding.
Where are you starting?
208lessons
8paths
0day streak
0%explored
Start your first lesson
Choose a learning path below or search the library. Progress saves in your browser.
Learning paths
Pick a track — progress rings update as you complete lessons.
4 lessons
8mResearchAdvanced
2025 Peptide Therapy Review: Why Human Data Still Lags the Hype
A 2025 review makes the same point the peptide world keeps avoiding: some compounds have real human data, and many popular names still do not.
9mResearchAdvanced
Retatrutide Phase 3 Results: What They Mean for Appetite, Lean Mass, and Adherence
The real test for retatrutide is not whether it moves the scale. It is whether it makes the plan easier to follow without flattening training, energy, or lean mass.
9mPeptidesIntermediate
MOTS-C in July 2026: The FDA Review, Human Data, and What to Track
MOTS-C sits at the intersection of mitochondrial signaling, metabolism, and longevity. July 2026 put it back in the spotlight for a reason.
9mPeptidesIntermediate
Therapeutic Peptides in Gerontology: What Healthy Aging Research Actually Shows
Healthy aging is not a slogan. It is a measurable question about inflammation, tissue repair, metabolic control, and whether a peptide has human data behind it.
Also available at /blog for legacy links.